South America Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)
The travel vaccines market in SAM is expected to grow from US$ 143.20 million in 2021 to US$ 243.85 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028.
The SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM. During the forecast period, the region is expected to continue its dominance due to an increase in the prevalence of regional diseases, rapid technological innovations, vaccine development, and an increasing geriatric population. Brazil is the major vaccine manufacturer in the region. The country is self-sufficient for 54% of vaccination needs, including DTP, DT for adults and infants, TT, HepB, and DTP combined vaccines (DTP-HB and DTP-HB-Hib), seasonal influenza vaccine, YF vaccine, and meningo AþC. Brazil is one of the major worldwide producers of the YF vaccine, with the lowest market price. Similar to Brazil, Argentina is also the largest country in the region. Argentina has an upper middle-income economy with a diversified industrial sector. The country’s GDP was US$ 123,369 million in 2021. The GDP of Argentina has grown at a compound rate of 6.8% over the last five years. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. The factors such as increasing focus on vaccine research, continuous advancements in vaccine development technologies, and increasing government spending on pharmaceutical R&D in the region are expected to boost the travel vaccines market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM travel vaccines market. The SAM travel vaccines market is expected to grow at a good CAGR during the forecast period.
SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
SAM Travel Vaccines Market Segmentation
SAM travel vaccines market is segmented into product, application, and country. The SAM travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The SAM travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM.
Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Travel Vaccines Market – By Product
1.3.2 SAM Travel Vaccines Market – By Application
1.3.3 SAM Travel Vaccines Market – By Country
2. SAM Travel Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Travel Vaccines Market– Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion
5. SAM Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Travel and Tourism is Growing
5.1.2 Growing Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
5.3.1 Awareness Regarding Vaccines
5.4 Future Trends
5.4.1 Continuous Ongoing Demand for Vaccines
5.5 Impact Analysis
6. Travel Vaccines Market – SAM Analysis
6.1 SAM Travel Vaccines Marker Revenue Forecast and Analysis
7. SAM Travel Vaccines Market Analysis – By Product
7.1 Overview
7.2 SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
7.3.1 Overview
7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
7.4.1 Overview
7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
7.5.1 Overview
7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8. SAM Travel Vaccines Market Analysis – By Application
8.1 Overview
8.2 SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
8.3.1 Overview
8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
8.4.1 Overview
8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
9. SAM Travel Vaccines Market – Country Analysis
9.1 Overview
9.1.1 SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)
9.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.2 Brazil: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.1.3 Brazil: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.2 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.1 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.2 Argentina: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.2.3 Argentina: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.3 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.1 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.2 Rest of SAM: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.3.3 Rest of SAM: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
10. Travel Vaccines Market–Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11. Company Profiles
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Merck & Co., Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novartis AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Abbott
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. Brazil: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Argentina: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Argentina: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Rest of SAM: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Rest of SAM: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Organic Developments Done by Companies
Table 8. Inorganic Developments Done by Companies
Table 9. Glossary of Terms, SAM Travel vaccines Market
LIST OF FIGURES
Figure 1. SAM Travel Vaccines Market Segmentation
Figure 2. SAM Travel Vaccines Market – By Country
Figure 3. SAM Travel Vaccines Market Overview
Figure 4. SAM Outbound Segment Held Largest Share of Travel Vaccines Market by Product
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. Expert Opinion
Figure 8. SAM Travel Vaccines Market Impact Analysis of Drivers and Restraints
Figure 9. SAM Travel Vaccines Market – Revenue Forecast and Analysis – 2019 - 2028
Figure 10. SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
Figure 11. SAM Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 16. SAM Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 19. SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)
Figure 20. Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 21. Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 22. Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 23. Growth Strategies in the Travel Vaccines Market, (%)
- Abbott
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM travel vaccines market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution